News|Articles|July 3, 2025
FDA Action Update, June 2025: Approval, Acceptance, Expanded Indication
Author(s)Isabella Ciccone, MPH
Catch up on any of the neurology news headlines you may have missed over the course of June 2025, compiled all into one place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in June 2025, making a number of decisions on potential new therapeutic agents including granting an approval, accepting a new drug application, and greenlighting an expanded indication.
Advertisement
Advertisement